Project Grant R24OD042579
- The National Institutes of Health Office of the Director awarded The General Hospital Corporation (Massachusetts General Hospital) $800,824 through the Research Infrastructure Programs (CFDA 93.351) grant program on July 15, 2026, to develop preclinical zebrafish xenograft models for human tissue transplantation studies. The project will optimize engraftment of human tissues into immune-deficient and immune-ablated zebrafish, develop radiation-ablation models as faster transplantation platforms,...
- The National Institute of Environmental Health Sciences awarded $662,340 to the University of Massachusetts on August 13, 2026, under the Environmental Health program (CFDA 93.113) to investigate how per- and polyfluoroalkyl substances (PFAS) disrupt exocrine pancreas development and function in early life stages and identify recovery pathways through mechanistic study of the NRF2 pathway using transgenic zebrafish embryos. The research employs transgenic Danio rerio (zebrafish) embryos to...
- The National Institutes of Health Office of the Director awarded $731,592 to the Regents of the University of Minnesota on June 15, 2026, under the Research Infrastructure Programs (CFDA 93.351) to develop, standardize, and disseminate cryopreservation methods for zebrafish embryos. The project runs through February 28, 2030, with performance at the university's Minneapolis, Minnesota campus. The award funds development of reliable cryogenic storage and shipping protocols for zebrafish embryos...
- The Department of Health and Human Services National Institutes of Health Office of the Director awarded Duke University $444,125 on July 1, 2026, under the Research Infrastructure Programs (CFDA 93.351) to develop zebrafish tools for enteroendocrine hormone biology research. The award funds development of methods for visualizing enteroendocrine cell (EEC) physiology in live zebrafish, including identification and characterization of EEC subtypes that express distinct hormone transcripts and...
- The National Institutes of Health Office of the Director awarded University of Massachusetts Lowell $347,601 on August 15, 2026, under the Research Infrastructure Programs (CFDA 93.351) to acquire an ATS SP Hull Lyostar 4.0 research-scale freeze dryer for the university's core research facility. The freeze dryer will establish a regional hub for lyophilization research, enabling researchers across biomedical engineering, chemistry, pharmaceutical sciences, plastics engineering, and environmental...
- The National Institutes of Health Office of the Director awarded $812,443 to the University of Pennsylvania on July 1, 2026, under the Research Infrastructure Programs (CFDA 93.351) to develop an engineered protein tag resource for live imaging and functional studies in zebrafish. The award funds development of a software package that identifies optimal epitope tag integration sites within zebrafish protein sequences using conservation analysis and machine-learning-based protein structure...
- The National Institute of Child Health and Human Development awarded University of Massachusetts Boston $577,974 on August 24, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to investigate RNA binding proteins in the maintenance of male fertility and spermatogenesis. The research uses zebrafish as a model organism to elucidate how RNA regulation by ADAD1 proteins controls spermatogonial stem cell maintenance and differentiation during continuous...
- Federal Project Grant Award Summary The University of New Mexico received $173,434 in federal funding awarded on August 15, 2025, under the Research Infrastructure Programs (CFDA 93.351), administered by the Office of the Director of the National Institutes of Health. This one-year project grant supports the modernization and expansion of recirculating zebrafish tank systems and monitoring equipment at the Castetter Hall Animal Resource Facility on UNM's main campus. The funded equipment...
- The National Science Foundation Division of Molecular and Cellular Biosciences awarded the University of Massachusetts Medical School $1.261 million on August 1, 2026, under the Biological Sciences program (CFDA 47.074) to conduct collaborative research on the molecular and neural mechanisms controlling circatidal rhythms in the crustacean Parhyale hawaiensis. The research identifies genes that encode the circatidal clock—an internal ~12.4-hour biological timekeeper that enables marine animals...
- The National Institute of Child Health and Human Development awarded the University of Massachusetts $478,453 on September 1, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to characterize approximately 150 early lethal mouse phenotypes occurring between fertilization and organogenesis as part of large-scale analysis of International Mouse Phenotyping Consortium (IMPC) early lethal phenotypes. The recipient will phenotype knockout alleles to...
The National Institutes of Health Office of the Director awarded the University of Massachusetts $503,073 on August 1, 2026, under the Research Infrastructure Programs (CFDA 93.351) to systematically evaluate extrinsic variables affecting biological endpoints in zebrafish research and improve experimental rigor and reproducibility across biomedical disciplines. The recipient will acquire state-of-the-art equipment to standardize and measure environmental factors in zebrafish research: embryo incubators capable of monitoring and controlling light, temperature, and humidity; a multi-camera array microscope for morphology and behavior endpoints; and an aquatics data system to monitor, record, and automatically adjust water quality parameters. Leveraging four independently managed zebrafish facilities at the University of Massachusetts Amherst, the project will systematically evaluate extrinsic factors including rearing media, light cycle, vessel size, population density, and feeding at embryonic and larval life stages, as well as parental diet and facility-level water quality and temperature monitoring. The evaluation will assess how these variables affect biological endpoints across multiple physiological and organ systems, including developmental toxicology impacts, pancreas and liver structure and function, antioxidant responses, behavior, neurogenesis, and craniofacial development. Results will address gaps in standardization across laboratories and enhance shared resources within the zebrafish research community, while supporting the integration of zebrafish as a key component of new approach methodologies in biomedical research. The period of performance extends from August 1, 2026, through April 30, 2030, with performance at Hadley, Massachusetts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $503.1k | 7/28/26 |